Controlling cardiac risk factors may significantly lower cancer risk, as research shows a direct correlation between managing these factors and reduced malignancy rates. Innovative genetic approaches are being employed to identify protective pathways against both heart disease and cancer. Notably, a drug initially developed for inflammation has shown promise in preventing not only cardiovascular events but also reducing cancer incidence, highlighting the interconnectedness of these two leading health threats.
